By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



3 Golda Meir Street
Park ha'mada Nes
Ziona    74036  Israel
Phone: 972-8-9313090 Fax: 972-8-9313091


Medical Device

Company News
IDRI & NanoPass Sign Agreement to Develop An Intradermal rvRNA-Based Zika Virus Vaccine 2/14/2017 6:46:00 AM
NanoPass To Present Newly Released Data On Intradermal Flu Vaccination At The World Vaccine Congress (WVC) 2016 In Barcelona 10/10/2016 8:16:14 AM
West Pharmaceutical Services Makes Investment In NanoPass 4/25/2016 8:25:13 AM
NanoPass To Supply MicronJet600 Device To Immune Design For Use In Zvex-Based Oncology Immunotherapy Products 9/8/2015 10:09:45 AM
NanoPass Will Present 8 Years Of Clinical Experience With Its Micronjet600 Device In The Coming Skin Vaccination Summit 2015 Meeting 8/31/2015 7:25:14 AM
NanoPass Grants An Exclusive License To Circassia Pharmaceuticals, For Use Of Its Micronjet600 Device In Allergy Testing In The US 5/6/2015 7:47:45 AM
NanoPass Secures Series B Investment to Accelerate Commercialization of its Intradermal Delivery Products 7/30/2012 9:56:44 AM
NanoPass Grants a License to its Intradermal Delivery Device to Circassia for Use in Multiple Allergy Vaccine Fields 9/15/2011 10:48:56 AM
Infectious Disease Research Institute (IDRI) to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests 8/31/2009 1:29:36 PM
New Microneedle-Based Injection Device From NanoPass 8/14/2009 7:24:01 AM